"In the midst of an escalating pandemic, ProBioGen successfully managed safety, staffing, and procurement to maintain aggressive timelines for Pionyr's two first-in-class TME-directed afucosylated monoclonal antibodies."

SVP, Technical Operations | Pionyr Immunotherapeutics, Inc.

"Thanks to ProBioGen's continuous support and regularly provided valuable information — not only on technical challenges but also urgent issues associated with the project — our teams were able to bring a product from their facility to clinic as scheduled, within several months, here in Japan."

Director, CMC Development | Chiome Bioscience Inc.

"In ProBioGen, we see a company that values scientific contribution and enables high-quality drug development for customers, which ultimately benefits the patients we all serve."

Senior Director, Biologics Development | Celgene Corporation